SGLT2 versus DPP4 inhibitors for type 2 diabetes

Lancet Diabetes Endocrinol. 2013 Nov;1(3):168-70. doi: 10.1016/S2213-8587(13)70095-0. Epub 2013 Sep 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzhydryl Compounds / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucosides / therapeutic use*
  • Humans
  • Male
  • Pyrazines / therapeutic use*
  • Sitagliptin Phosphate
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Triazoles / therapeutic use*

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Pyrazines
  • Sodium-Glucose Transporter 2 Inhibitors
  • Triazoles
  • empagliflozin
  • Sitagliptin Phosphate